Remdesivir fails to prevent Covid-19 deaths in massive trial

Remdesivir fails to prevent Covid-19 deaths in massive trial.

Remdesivir, the only antiviral drug sanctioned by the US Food and Drink Administration (FDA) to treat Covid-19, has “little or no effect” in preventing patient mortality, according to WHO’s ‘Solidarity’ study.

The trial “to evaluate the effectiveness of four drugs for Covid-19 treatment” involved more than 11,300 participants at hundreds of hospitals in 30 different countries.

Treatments used included remdesivir, hydroxychloroquine, lopinavir, interferon, or interferon plus lopinavir, given individually or in combination.


Around 4,100 Covid-19 participants were given no drug treatment at all.

None of the drugs or drug cocktails prevented mortality, risk for mechanical ventilation, or length of hospital stay compared with patients who received no drug treatment.

“We would like to thank all of the patients and clinicians who participated so far in this unprecedented study, and the countries and hospitals who covered the costs of the trial,” said WHO.

It added: “The Solidarity Trial is still recruiting about 2,000 patients every month and will assess other treatments, including monoclonal antibodies and new antivirals”.

Gilead Sciences disagreed with WHO’s conclusions, reports the New York Times, pointing out the wide range of treatments evaluated under a wide range of circumstances.

More rigorous investigations have demonstrated a benefit, argued the drug manufacturer.

However, the authors of the WHO study state their findings are “unpromising” for remdesivir, initially developed as a therapy for Ebola and hepatitis C.

Thank you for taking the time to read this news article “Remdesivir fails to prevent Covid-19 deaths in massive trial”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Euro Weekly News is delighted to continue be able to bring you a range of News from around Spain in English and Global News live as it happens.

Euro Weekly News doesn’t cost you anything but your internet connection. Whether it’s bringing you the local Spanish news or the International news today, we’ve got you covered!

Euro Weekly News, the leading free local and national newspaper in Spain, the people’s paper, we lead others follow!

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Tara Rippin

Tara Rippin is a reporter for Spain’s largest English-speaking newspaper, Euro Weekly News, and is responsible for the Costa Blanca region.
She has been in journalism for more than 20 years, having worked for local newspapers in the Midlands, UK, before relocating to Spain in 1990.
Since arriving, the mother-of-one has made her home on the Costa Blanca, while spending 18 months at the EWN head office in Fuengirola on the Costa del Sol.
She loves being part of a community that has a wonderful expat and Spanish mix, and strives to bring the latest and most relevant news to EWN’s loyal and valued readers.

Share your story with us by emailing, by calling +34 951 38 61 61 or by messaging our Facebook page